Last updated: September 5, 2023
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Urticaria
Hives (Urticaria)
Treatment
Placebo
Vitamin D
Clinical Study ID
NCT05497596
CMUH111-REC3-066
Ages < 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Experimental group: patients with chronic spontaneous urticaria under the age of 18 .
- Control group: healthy children under the age of 18 (eg, healthy siblings of sickchildren).
Exclusion
Exclusion Criteria:
- Recruit patients who have used antibiotics, systemic steroids, and immunosuppressantsin the previous month.
- Patients with C1 esterase inhibitor deficiency, lymphocytopenia, thrombocytopenia,severe diseases involving heart, liver, or kidney, metabolic disease, or autoimmunedisease.
Study Design
Total Participants: 150
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
August 02, 2022
Estimated Completion Date:
March 31, 2025
Study Description
Connect with a study center
China Medical University Hospital
Taichung, 404
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.